Q&A

The Challenges Of Biopharmaceutical Quality

Samsung

Today more than ever, the quality functions in biopharmaceutical manufacturing are under pressure.  And that pressure is unlikely to be relieved any time soon due to an unprecedented level of regulatory and political scrutiny (primarily from the U.S. FDA and EMA) combined with a global market rife with a multitude of complex quality standards. It’s a scenario that has quality professionals struggling to embrace new and more efficient ways of manufacturing while maintaining compliance.

In the following Q&A, Nick Beaumont, VP and managing director of Samsung BioLogics who is responsible for the Quality Assurance Center of the company, answers some important quality-related questions regarding biopharmaceutical manufacturing that you will likely find helpful.

VIEW THE Q&A!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: